Nishikubo, H.; Ma, D.; Sano, T.; Imanishi, D.; Sakuma, T.; Fan, C.; Yamamoto, Y.; Yamamori, M.; Yashiro, M.
Correction: Nishikubo et al. FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities. Int. J. Mol. Sci. 2025, 26, 10777. Int. J. Mol. Sci. 2026, 27, 665.
https://doi.org/10.3390/ijms27020665
AMA Style
Nishikubo H, Ma D, Sano T, Imanishi D, Sakuma T, Fan C, Yamamoto Y, Yamamori M, Yashiro M.
Correction: Nishikubo et al. FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities. Int. J. Mol. Sci. 2025, 26, 10777. International Journal of Molecular Sciences. 2026; 27(2):665.
https://doi.org/10.3390/ijms27020665
Chicago/Turabian Style
Nishikubo, Hinano, Dongheng Ma, Tomoya Sano, Daiki Imanishi, Takashi Sakuma, Canfeng Fan, Yurie Yamamoto, Motohiro Yamamori, and Masakazu Yashiro.
2026. "Correction: Nishikubo et al. FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities. Int. J. Mol. Sci. 2025, 26, 10777" International Journal of Molecular Sciences 27, no. 2: 665.
https://doi.org/10.3390/ijms27020665
APA Style
Nishikubo, H., Ma, D., Sano, T., Imanishi, D., Sakuma, T., Fan, C., Yamamoto, Y., Yamamori, M., & Yashiro, M.
(2026). Correction: Nishikubo et al. FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities. Int. J. Mol. Sci. 2025, 26, 10777. International Journal of Molecular Sciences, 27(2), 665.
https://doi.org/10.3390/ijms27020665
